Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
USA – Arbor Biotechnologies, a genome-editing company discovering and developing the next generation of genetic medicines, has announced the completion of a U$215 million Series B financing to advance the…
Read More
UNITED KINGDOM – GlaxoSmithKline Plc (GSK) has reported positive trial results for Daprodustat, a potential blockbuster anemia pill that the drugmaker hopes will bolster its pharma portfolio as it prepares…
Read More
USA – FibroGen Inc said has announced that the U.S. Food and Drug Administration has declined to approve its treatment for anemia of chronic kidney disease, citing the need for…
Read More